A spokesperson for the US Department of State told Pharmaceutical Technology that the “American people have paid more than enough” to the WHO.

GD analyst Tanuj Sircar believes that amlitelimab will find its best use case as a second or third-line systemic therapy in AD. Image credit: Pramoda Photography via ShutterStock.com. Sanofi has ...

IGC incorporates AI to optimise trials, enhance patient targeting, and accelerate drug discovery. Credit: IGC Pharma. IGC Pharma has expanded its CALMA Phase II clinical trial by adding Integrative ...

Genespire is looking to take its single-dose gene therapy, GENE202, to the clinic by the end of 2026, where it will be ...

BBH has entered a partnership with PhaseWell Research aimed at expanding access to neuropsychiatric clinical trials.

Corcept Therapeutics has seen its stock rise on the Phase III OS data. Image credit: Thomas Fuller/SOPA Images/LightRocket via Getty Images Corcept Therapeutics’ stock has risen 14% after its ...

Lipocine has completed the enrolment and participant dosing in its Phase III clinical trial investigating LPCN 1154 to treat ...

Analysis published in the American Society of Nephrology highlighted strong evidence that ERAs benefit chronic kidney disease ...

The UK DRI has announced an international research study to assess whether a finger-prick blood test could help diagnose ...

D3 Bio will begin a Phase I trial for patients with advanced solid tumours harbouring KRAS G12D mutations. Credit: Bohbeh creations / Shutterstock.com. D3 Bio has received the US Food and Drug ...

Insomnia seriously affects both physical and mental health. Credit: Tero Vesalainen / Shutterstock.com. Nxera Pharma has announced positive top-line results from its Phase III study of daridorexant ...

Atea showcased its Phase III HCV programme at JPM, positioning the regimen for test-and-treat adoption in 1,800 patients.